Literature DB >> 1398108

Myristoylation-dependent membrane targeting and release of the HTLV-I Gag precursor, Pr53gag, in yeast.

T Hayakawa1, T Miyazaki, Y Misumi, M Kobayashi, Y Fujisawa.   

Abstract

The unprocessed HTLV-I Gag precursor, Pr53gag, was synthesized in yeast, Saccharomyces cerevisiae. The synthesized Pr53gag was myristoylated, associated with the cellular membrane, and released into the culture medium. The released Pr53gag was pelleted by centrifugation at 100,000 x g for 2 h. Conversion of Gly2 to Ala allowed synthesis of a non-myristoylated soluble Pr53gag which was not released into the culture medium. These results suggest that the release of the HTLV-I Gag precursors Pr53gag, occurs in yeast in a myristoylation-dependent manner.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1398108     DOI: 10.1016/0378-1119(92)90282-t

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  4 in total

1.  The NH2-terminal domain of the human T-cell leukemia virus type 1 capsid protein is involved in particle formation.

Authors:  F Rayne; F Bouamr; J Lalanne; R Z Mamoun
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

2.  HIV type 1 Gag virus-like particle budding from spheroplasts of Saccharomyces cerevisiae.

Authors:  Sayuri Sakuragi; Toshiyuki Goto; Kouichi Sano; Yuko Morikawa
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-11       Impact factor: 11.205

3.  Efficient particle formation can occur if the matrix domain of human immunodeficiency virus type 1 Gag is substituted by a myristylation signal.

Authors:  P P Lee; M L Linial
Journal:  J Virol       Date:  1994-10       Impact factor: 5.103

4.  Structural Insights into the Mechanism of Human T-cell Leukemia Virus Type 1 Gag Targeting to the Plasma Membrane for Assembly.

Authors:  Dominik Herrmann; Lynne W Zhou; Heather M Hanson; Nora A Willkomm; Louis M Mansky; Jamil S Saad
Journal:  J Mol Biol       Date:  2021-07-21       Impact factor: 6.151

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.